The intraoperative effect of pentoxifylline on the inflammatory process and leukocytes in cardiac surgery patients undergoing cardiopulmonary bypass

Abstract

Background: Inflammation plays a pivotal role in the pathogenesis of organ dysfunction after cardiopulmonary bypass (CPB). The aim of this study was to investigate whether pentoxifylline (PTX) has effects on the inflammatory process and leukocytes in cardiac surgery patients undergoing CPB.

Material and methods: A double-blind, prospective, randomized, placebo-controlled study was undertaken to assess the effect of PTX on leukocyte counts, tumour necrosis factor-α (TNF-α), interleukin-6 (IL-6) and C-reactive protein (CRP) levels in 60 patients undergoing CPB for elective coronary artery bypass grafting. In 30 patients, 200 mg of PTX was added to 500 mL NaCl and perfused for 180 min after induction of anaesthesia and also 100 mg of PTX was added to the warm cardioplegic solution; another 30 patients received saline solution as placebo.

Results: All measurements were performed before PTX infusion (T0), after induction of anaesthesia (T1), 30 min after weaning from CPB (T2), and 6 hours (T3) and 24 hours postoperatively (T4). PTX did not change the percentage of eosinophils, basophils, neutrophils, monocytes, or lymphocytes, or CRP levels. In the control group, however, total leukocyte count and IL-6 level at T3 and T4 period were significantly higher than the study group. The progressive increment in TNF-α level observed at each period was also significantly prominent in the control group.

Conclusion: CPB-related whole body inflammatory response could be partially inhibited by intraoperative PTX administration. This effect of PTX would be helpful in preventing the well-known complications of CPB-induced systemic inflammation.

Get full access to this article

View all access options for this article.

References

Edmunds LH Jr. Inflammatory response to cardio-pulmonary bypass . Ann Thorac Surg 1998; 66: S12-S16 .

Asimakopoulos G , Smith PLC , Ratnatunga CP , Taylor KM. Lung injury and acute respiratory distress syndrome after cardiopulmonary bypass . Ann Thorac Surg 1999; 68: 1107-1115 .

Downing SW , Edmunds LH, Jr. Release of vasoactive substances during cardiopulmonary bypass . Ann Thorac Surg 1992; 54: 1236-1243 .

Wachtfogel YT , Kucich U , Greenplate J et al. Human neutrophil degranulation during extracorporeal circulation . Blood 1987; 69: 324-330 .

Rinder CS , Bonan JL , Rinder HM et al. Cardiopulmonary bypass induces leukocyte-platelet adhesion . Blood 1992; 79: 1201-1205 .

Gadaleta D , Fahey AL , Verma M et al. Neutrophil leukotriene generation increases after cardiopulmonary bypass . J Thorac Cardiovasc Surg 1994; 108: 642-647 .

Butler J , Parker D , Pillai R et al. Effect of cardiopulmonary bypass on systemic release of neutrophil elastase and tumor necrosis factor . J Thorac Cardiovasc Surg 1993; 105: 25-30 .

Casey LC. Role of cytokines in the pathogenesis of cardiopulmonary-induced multisystem organ failure . Ann Thorac Surg 1993; 56: S92-S96 .

Gott JP , Cooper WA , Schmidt FE et al. Modifying risk of extracorporeal circulation: trial of four antiinflammatory strategies . Ann Thorac Surg 1998; 66: 747-754 .

10.

Royston D. The inflammatory response and extracorporeal circulation . J Cardiothorac Vasc Anesth 1997; 11: 341-354 .

11.

Ward A , Clissold SP. Pentoxifylline. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy . Drugs 1987; 34: 50-97 .

12.

Schade UF. Pentoxifylline increases survival in murine endotoxic shock and decreases formation of tumor necrosis factor . Circ Shock 1990; 31: 171-181 .

13.

Jansen NJG , van Oeveren W , Gu YJ et al. Endotoxin release and tumor necrosis factor formation during cardiopulmonary bypass . Ann Thorac Surg 1992; 54: 744-748 .

14.

Hennein HA , Ebba H , Rodriguez JL et al. Relationship of the proinflammatory cytokines to myocardial ischemia and dysfunction after uncomplicated coronary revascularization . J Thorac Cardiovasc Surg 1994; 108: 626-635 .

15.

Pollice PF , Rosier RN , Looney RJ et al. Oral pentoxifylline inhibits release of tumor necrosis factor-alpha from human peripheral blood monocytes: a potential treatment for aseptic loosening of total joint components . J Bone Joint Surg Am 2001; 83: 1057-1061 .

16.

Witkamp R , Monshouwer M. Signal transduction in inflammatory processes, current and future therapeutic targets: a mini review . Vet Q 2000; 22: 11-16 .

17.

Miller BE , Levy JH. The inflammatory response to cardiopulmonary bypass . J Cardiothorac Vasc Anesth 1997; 11: 355-366 .

18.

Van Snick J. Interleukin-6: an overview . Annu Rev Immunol 1990; 8: 253-278 .

19.

Kawamura T , Wakusawa R , Okada K , Inada S. Evaluation of cytokines during open heart surgery with cardiopulmonary bypass: participation of interleukin- 8 and 6 in reperfusion injury . Can J Anaesth 1993; 40: 1016-1021 .

20.

Steinberg JB , Kapelanski DP , Olson J , Weiler JM. Cytokine and complement levels in patients undergoing cardiopulmonary bypass . J Thorac Cardiovasc Surg 1993; 106: 1008-1016 .

21.

Gale SC , Hokama JY , Ritter LS et al. Pentoxifylline reduces coronary leukocyte accumulation early in reperfusion after cold ischemia . Ann Thorac Surg 2001; 71: 1305-1311 .

22.

Pasquier C , Franzini EAZ , Kaouadji M , Hakim J. Gamma pulse radiolysis study of pentoxifylline, a methylxanthine . Int J Rad Biol 1991; 60: 433-437 .

23.

Wehlin L , Vedin J , Vaage J , Lundahl J. Activation of complement and leukocyte receptors during on- and off-pump coronary artery bypass surgery . Eur J Cardiothorac Surg 2004; 25: 35-42 .

24.

Staubach KH , Schroder J , Stuber F et al. Effect of pentoxifylline in severe sepsis: a double-blind, placebo-controlled study . Arch Surg 1998; 133: 94-100 .

25.

Sigurdsson GH , Youssef H. Effects of pentoxifylline on hemodynamics, gas exchange and multiple organ platelet sequestration in experimental endotoxic shock . Acta Anaesthesiol Scand 1993; 37: 396-403 .

26.

Levi M , ten Cate H , Bauer KA et al. Inhibition of endotoxin induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees . J Clin Invest 1994; 93: 114-120 .